Viking Therapeutics (VKTX) Amortizatization of Intangibles (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Amortizatization of Intangibles came in at $885000.0 in Q2 2026, down 62.99% year-over-year from $2.4 million in Q2 2025, and down 31.55% quarter-over-quarter from $1.3 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Amortizatization of Intangibles across 12 years of filings, most recently posting $885000.0 for Q2 2026.
- In Q2 2026, Amortizatization of Intangibles fell 62.99% year-over-year to $885000.0; the TTM figure through Jun 2026 stood at $5.9 million (down 59.14% YoY), while the FY2025 annual figure was $9.3 million, down 46.23% from the prior year.
- Amortizatization of Intangibles came in at $885000.0 for Q2 2026 at Viking Therapeutics, down from $1.3 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $5.4 million in Q2 2024 to a low of -$1.4 million in Q4 2022.
- Average Amortizatization of Intangibles over 5 years is $2.1 million, with a median of $2.0 million recorded in 2025.
- Year-over-year, Amortizatization of Intangibles jumped 2114.79% in 2023 and plunged 62.99% in 2026.
- Over 5 years, Amortizatization of Intangibles stood at -$1.4 million in 2022, then surged by 288.16% to $2.7 million in 2023, then surged by 49.19% to $4.0 million in 2024, then slumped by 57.06% to $1.7 million in 2025, then sank by 48.87% to $885000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $885000.0 in Q2 2026, $1.3 million in Q1 2026, and $1.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | - |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 984.00 Mn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 600.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | 885,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 885,000.00 |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 2.39 Mn |
| Mar 31, 2025 | 3.13 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Jun 30, 2024 | 5.44 Mn |
| Mar 31, 2024 | 2.82 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Sep 30, 2023 | 3.15 Mn |
| Jun 30, 2023 | 1.97 Mn |
| Mar 31, 2023 | 389,000.00 |
| Dec 31, 2022 | -1.44 Mn |
| Sep 30, 2022 | 142,000.00 |
| Mar 31, 2022 | 77,000.00 |
| Dec 31, 2021 | -4.13 Mn |
| Sep 30, 2021 | 75,000.00 |
| Dec 31, 2019 | 477,000.00 |
API Access
Viking Therapeutics Amortizatization of Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortizatization-of-intangibles", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();